Many tumor surface antigens are potential targets of BsAbs, such as CD123, CD33, FMS-like tyrosine kinase 3 (FLT3), C-type lectin domain family 12 member A (CLEC12A), and Wilms' tumor gene 1 (WT1) [76]. This evidence concerns the gene CLEC12A and neoplasm.